Previous studies have identified the NK homeobox gene bagpipe and the FoxF fork head domain gene biniou as essential regulators of visceral mesoderm development in Drosophila. Here we present additional genetic and molecular information on the functions of these two genes during visceral mesoderm morphogenesis and differentiation. We show that both genes are required for the activation of b3Tub60D in the visceral mesoderm, which encodes b3 tubulin. We demonstrate that a 254 bp derivative of a previously defined visceral mesodermspecific enhancer element, vm1, from b3Tub60D contains one specific in vitro binding site for Bagpipe and two such sites for Biniou. While the wild-type version of the 254 bp enhancer is able to drive significant levels of reporter gene expression within the entire trunk visceral mesoderm, mutation of either the Bagpipe or the Biniou binding sites within this element results in a severe decrease of enhancer activity. Moreover, mutation of all three binding sites for Bagpipe and Biniou, respectively, results in the complete loss of enhancer activity. Together, these observations suggest that Bagpipe and Biniou serve as direct, partially redundant, and tissue-specific activators of the terminal differentiation gene b3Tub60D in the visceral mesoderm. q
Introduction
The Drosophila trunk visceral mesoderm consists of a dorsal internal layer of mesodermal cells that are destined to form midgut musculature (Campos-Ortega and Hartenstein, 1997) . While most of these cells will form binucleate circular midgut muscle fibers, a small percentage of them contributes to the longitudinal muscle fibers of the midgut upon fusion with caudally-derived visceral mesodermal cells (San Martin et al., 2001; Klapper et al., 2002) . Morphogenesis and differentiation of the midgut musculature requires the expression of many different proteins that are involved in cell adhesion, myoblast fusion, cell signaling, as well as determination of ultrastructural and contractile properties. In order to obtain insight into the molecular control of midgut differentiation, we need to understand the pathways that coordinate the expression of genes encoding this type of proteins and know how these pathways are connected to the early mesoderm patterning processes that generate the visceral mesoderm.
Previous work has identified two transcription factors, the NK homeodomain protein Bagpipe and the FoxF family member Biniou, as the earliest gene products that are restricted to the anlagen of the trunk visceral mesoderm and are crucial for visceral mesoderm differentiation (Azpiazu and Frasch, 1993; Zaffran et al., 2001) . In response to inductive Dpp signals, mesodermal activity of the NK homeobox gene tinman (tin), and negative regulation by Wingless signals via their downstream targets sloppy paired (slp1 and slp2), bagpipe (bap) and biniou (bin) become co-expressed in metameric patches of cells within the dorsal mesoderm (Azpiazu and Frasch, 1993; StaehlingHampton et al., 1994; Frasch, 1995; Riechmann et al., 1997; Lee and Frasch, 2000; Zaffran et al., 2001) . It is these cells that will form trunk visceral mesoderm. bin is downstream of bap in this pathway, but like bap, it also appears to receive direct inputs from Dpp and Wg/Slp. Unlike bap, which is expressed only transiently, bin expression continues in the gut musculature until it is fully differentiated, indicating that it may not only function in the formation but also in the terminal differentiation of the visceral mesoderm (Zaffran et al., 2001) .
Functional loss of either bap or bin was shown to cause similar defects in visceral mesoderm development, which ultimately result in the absence of any midgut musculature in late-stage embryos. Although a dorsal/interior layer of mesoderm is formed from metameric cell clusters in bap and bin mutants, the cells of this layer fail to express several visceral mesoderm-specific markers, including fasciclin III, Goa , and vimar (Zaffran et al., 2001) . Subsequent morphogenetic processes that are typical for later stages of visceral mesoderm differentiation do not occur in bap or bin mutant backgrounds and the majority of the cells fuse with somatic muscle precursors to form body wall instead of gut musculature. Conversely, ectopic mesodermal expression of bin leads to ectopic activation of early visceral mesoderm markers (Zaffran et al., 2001) . Altogether, these and other data show that bap and bin have major functions in specifying the identities of trunk visceral mesoderm cells.
The similarities of the genetic functions of bap and bin as well as the known regulatory relationships between the two genes raise the question of the relative contribution of each gene to the activation of downstream targets that regulate visceral mesoderm morphogenesis and gut muscle differentiation. For example, it may be that bap is mainly required to allow activation of bin expression, which is then sufficient for the activation of patterning and differentiation genes. The observed stronger effects of ectopic bin as compared to ectopic bap expression (Zaffran et al., 2001; M. Frasch, unpublished data) would be in agreement with this notion. Additional support comes from our studies of a visceral mesoderm-specific enhancer of dpp, which is expressed in parasegment 7 of the visceral mesoderm where Dpp plays a role in visceral mesoderm and midgut morphogenesis. It was shown that this enhancer requires three specific Bin binding sites in order to be active, in addition to other sequences that cause spatial restriction of its activity (Zaffran et al., 2001) . By contrast, Bap does not bind to this enhancer, which suggests that Bap is required only indirectly, through the activation of bin expression, for the regulation of dpp within the visceral mesoderm. However, the possibility remains that other genes are specific downstream targets of bap, or require both bin and bap for their activation.
In our present report we examine the molecular control of the activation of the b3 tubulin gene, bTub60D, in the trunk visceral mesoderm. b3 tubulin is known to contribute to the normal cytoarchitecture of visceral mesoderm cells, which is essential for the proper functioning of the gut (Dettman et al., 1996) . The regulation of bTub60D has already been studied in considerable detail and an intronic enhancer, termed vm1, was found to mediate expression specifically within the cells of the trunk visceral mesoderm (Gasch et al., 1989; Kremser et al., 1999) . In particular, it was shown that this ,500 bp enhancer contains two binding sites for the homeotic factor Ubx as well as a binding site for Tinman. Mutations of both Ubx sites showed that they are involved in the upregulation of enhancer activity within parasegments 6 and 7, and results from deletions of sequences that included the Tinman binding site indicated that Tin may be involved in the general activation of bTub60D in the visceral mesoderm. Moreover, data from additional deletion constructs suggested the presence of functional binding sites for yet unknown factors.
In light of our genetic data with bap and bin we have performed further functional dissection experiments in vivo in combination with in vitro protein/DNA binding assays with this enhancer. We show that a variant of vm1, which lacks the Ubx binding sites, requires the genetic activities of bap and bin for its activity in the visceral mesoderm. We demonstrate that the previously identified Tin binding site has also high affinity for Bap and that, in addition, the enhancer includes two specific binding sites for Bin. Mutation of either the Bap/Tin binding site or of both Bin binding sites cause a significant reduction, but not a complete loss of enhancer activity. However, when the binding sites for Bap/Tin and Bin are mutated in combination the enhancer is rendered completely inactive. Thus, bTub60D provides an example of a differentiation gene that requires the combined and partially redundant activities of Bin and Bap, and possibly also Tin, as direct activators in the trunk visceral mesoderm.
Results
To test whether the expression of b Tub60D in the trunk visceral mesoderm depends on the activity of two known visceral mesoderm regulators, bap and bin, we examined bTub60D protein expression in embryos that were mutant for the respective gene. In addition, the embryos carried a bap-lacZ transgene as an independent marker for the early visceral mesoderm (Zaffran et al., 2001 ) which, in a wildtype background, is co-expressed with b3 tubulin ( show that the activities of both bap and bin are required for normal b3-tubulin expression in the trunk visceral mesoderm. Hinz et al. (1992) defined a visceral mesoderm-specific enhancer element from the bTub60D gene, vm1, that was contained in the reporter construct pWHb3-14 and consisted of 515 bp of enhancer sequences from the first intron of this gene (13154 to 13669) ( Fig. 2A,B) . While it was shown that two Ubx binding sites within this enhancer are involved in increasing its activity within parasegments (PS) 6 and 7 (Kremser et al., 1999) , our present data suggested that bap and/or bin may act as direct regulator(s) of the broad basal activity of this enhancer in the entire trunk visceral mesoderm. To test this possibility we crossed a derivative of pWHb3-14, in which the Ubx sites were deleted (pWHb3-14/DUbx1 1 2; see Fig. 2C ), into bap and bin mutant backgrounds. While in the wild-type back- (nt 3160-3172 and 3186-3206, respectively) . Elements 1-8 that were deleted in the study by Kremser et al. (1999) are shown below and denoted as e1-8. (C) Summary of vm1 enhancer derivatives. Constructs analyzed by Hinz et al. (1992) ; Kremser et al. (1999) , and the present study are indicated by the bars. The b 3-17 element used in the present study extends from 13252 to 13506. ground this enhancer derivative is driving significant (though anteroposteriorly graded) levels of bgal expression in a continuous row of visceral mesoderm cells (Fig. 3A) , in a bap null mutant background enhancer activity is completely lost in this tissue (Fig.3B ). Likewise, a strong reduction of enhancer activity driven by pWHb3-14/DUbx1 1 2 is also observed in a bin null mutant background, although in this case some residual visceral mesoderm cells are still expressing low levels of the reporter gene (Fig. 3C) . In order to clarify whether these genetic interactions reflect any direct interactions of the bap or bin products with vm1 enhancer sequences we performed in vitro DNA-binding experiments with the two proteins. DNaseI protection assays with bacterially expressed Bin fusion proteins revealed two strongly protected sequences, termed BIN-I and BIN-II, within vm1 ( Fig. 4A ; see also Fig. 2 ). Closer inspection of these sequences showed that BIN-I contains overlapping tandem copies and BIN-II a single copy of a canonical binding motif for fork head domain proteins (Fig. 4D) . The specificities of these in vitro binding activities are further corroborated by the results from gel mobility shift experiments. In particular, these data show that both BIN-I and BIN-II oligonucleotides can compete for binding of Bin to vm1, whereas analogous oligonucleotides in which the canonical fork head domain binding sequence was mutated fail to compete (Fig.4C) .
Bap fusion proteins also produced a strongly protected region in DNaseI footprinting experiments ( Fig. 4B ; see also Fig. 2 ). The protected sequence contains an overlapping tandem repeat of a canonical NK-homeodomain binding motif (Fig. 4D) , which was previously shown to bind Tinman (Kremser et al., 1999) . Indeed, the footprints produced with Bap and Tin on this sequence are almost indistinguishable (Fig. 4B) .
In preparation for functional tests of the Bin and Bap binding sites in vivo we generated a shorter version of vm1, termed b3-17, which lacks 5 0 and 3 0 sequences that were previously shown to be dispensable for driving basal levels of visceral mesoderm expression (13252 to 13506; Fig. 2C ; Kremser et al., 1999) . As predicted, b3-17-driven bgal expression occurs in a uniform pattern and at intermediate levels within the visceral mesoderm (Fig. 5A,B) . Next we tested the effects of mutant Bin and Bap binding sites on the in vivo activity of the b3-17 enhancer element.
As shown in Fig. 5C -F, mutation of either BIN-I (b3-17 bin-Imt) or BIN-II b3-17 (bin-IImt) results in a strong decrease of b3-17 enhancer activity. Although we expected that the activities of BIN-I and BIN-II may be partially redundant, simultaneous mutation of both binding sites did not result in a significant reduction of enhancer activity beyond the levels seen with mutations in either binding site, particularly BIN-II, alone (b3-17 bin-I 1 IImt; Fig. 5G,H) . Mutation of the Bap binding site also resulted in a strong reduction but not a complete loss of enhancer activity within the visceral mesoderm (Fig. 5I,J) . To determine whether the residual enhancer activity of the mutated elements examined above is due to functional redundancy between the Bin or Bap binding sites we tested the effects of mutations in all three binding sites. As shown in Fig. 5K ,L, simultaneous disruption of all Bin and Bap binding sites within the b3-17 enhancer element results in the complete loss of enhancer activity, thus confirming that Bin and Bap have partially redundant roles in activating the vm1 enhancer of bTub60D.
Discussion
We have addressed herein the genetic and molecular mechanisms that activate a terminal differentiation gene, bTub60D, within the trunk visceral mesoderm during Drosophila embryogenesis. Our data show that activation of b Tub60D expression involves the direct binding of two regulators of visceral mesoderm development, the NK homeodomain protein Bap and the FoxF fork head domain protein Bin, to the visceral mesoderm-specific enhancer vm1 of b Tub60D. Mutation of all binding sites for these Fig. 3 . bin and bap are regulators of b 3-14 enhancer in vivo. Shown are wild-type, bin and bap embryos carrying the b 3-14/DUbx1 1 2-lacZ insertion and stained with bGal antibodies. (A) In the control strain, b 3-14/ D Ubx1 1 2, bGal is expressed all along the trunk visceral mesoderm, with a peak of intensity between PS7 and PS12 (arrowheads). In the visceral mesoderm of a bap mutant embryo (B) bGal protein is not detected in the visceral mesoderm layer. In a bin mutant embryo (C) there is weak residual bGal expression within PS7 to PS12 of the visceral mesoderm (arrowheads). two proteins within the context of this enhancer abolishes enhancer activity, showing that the combined activity of Bap and Bin is required for enhancer activation. The presence of residual enhancer activity, albeit at low levels, upon mutation of the binding sites for only one of the two factors indicates a certain degree of functional redundancy between Bap and Bin in this process. Despite this partial functional redundancy, bTub60D expression is almost completely absent in the visceral mesoderm of embryos mutant for either bap or bin. The observed differences in these two assays can be explained by the known regulatory relationships between bap and bin. Since bap is required for bin activation and bin is required for prolonged bap expression (Zaffran et al., 2001) , it is reasonable to conclude that neither bap nor bin mutant embryos are able to express Bin and Bap, respectively, at threshold levels that are sufficient to activate significant levels of b Tub60D through vm1.
Previous data, which we have confirmed in our present report, have shown that Tin, an NK homeodomain protein with similar binding specificity as Bap, can bind to the same site as Bap within vm1 (Kremser et al., 1999) . Although the tin gene is not actively expressed within the visceral mesoderm (except for a transient, segmentally interrupted pattern at stage 11), some of the Tin protein expressed in the early dorsal mesoderm perdures in the visceral mesoderm until ,stage 13, which would be compatible with a direct interaction with the vm1 enhancer. However, the absence of b Tub60D expression in bap mutant embryos, in which tin expression is largely normal, would suggest that a direct input from tin does either not occur or is not sufficient to activate b Tub60D. Hence, Bap appears to function as the major activator that binds to this site. The particular sequence at this site corresponds to an overlapping tandem repeat of two canonical NK homeodomain binding sites, which could allow the binding of a Bap homodimer or a Bap/Tin heterodimer. Of note, we have clear data showing that Bap and Tin can form specific heterodimer complexes in vitro and in yeast systems. However, we have not yet been successful in showing that such complexes are able to form at this particular binding site in vm1.
It is interesting to note that the Bap binding site is not only required for early vm1 activity but also in embryos after stage 12, even though bap is no longer expressed during these stages. We speculate that the binding of Bap during stage 11 may be required to establish an active chromatin structure, in the absence of which Bin is not able to activate the enhancer at later stages.
The residual enhancer activity upon mutation of Bin or Bap binding sites is largely observed in the middle portion of the visceral mesoderm, suggesting the influence of spatially restricted regulator(s). Indeed, the close spatial correlation between residual enhancer activity and Dppsignaling activity (S. Zaffran, M. Frasch, unpublished data) as well as the presence of putative Smad binding sites within vm1(13265: GGGCCG; 13289: CAGAC; 13431: CAGACGGCAGAC) suggests a role for direct inputs from Dpp in the regulation of vm1 enhancer activity. Thus, Smad complexes and Bap bound to vm1 sequences may act in a synergistic fashion, a situation that may be analogous to the synergistic activity of Smad and Tin during the induction of the Dpp-responsive enhancer of the tin gene (Xu et al., 1998) . However, the fact that this effect is only observed with a weakened version of the enhancer indicates that the Dpp-input plays a minor role during the normal activation of the bTub60D gene in the visceral mesoderm. Additional inputs, which may also be insignificant for b Tub60D regulation in the normal situation, could come from Wg and/or Hh and result in low levels of metameric expression with weakened enhancer constructs (Fig. 5I,F ,J; Bilder and Scott, 1988) .
Activation of the vm1 enhancer during stage 11 is restricted to the ventral row of visceral mesodermal cells, but is missing in the remaining cells of this tissue that also express Bap and Bin. Hence, the combination of Bap and Bin is required, but not sufficient for activating b Tub60D expression through vm1. Previous observations have shown that the region defined by deletion 3 (e3, 13439 to 13471; Fig. 2 ; Kremser et al., 1999) , which neither contains Bap nor Bin binding sites, is also required for normal enhancer activity. Therefore, this sequence may be a target of a yet unknown activity within the ventral row of visceral mesodermal cells that is required in combination with Bap and Bin to trigger vm1 activation. Recent reports have shown that these ventral cells are the equivalent of founder cells in the visceral mesoderm, which subsequently fuse with adjacent dorsal cells into binucleate syncytia (San Martin et al., 2001; Klapper et al., 2002) . Similar to the expression of dpp in PS 7 of the visceral mesoderm, vm1-lacZ expression spreads throughout the visceral mesoderm only upon fusion of founders with fusion-competent cells.
Combined with previous data, our current results define a continuous regulatory cascade of gene activation that initiates with the regulation of genes which pattern the early mesoderm and concludes with the activation of a terminal differentiation gene in the visceral mesoderm. Specifically, this pathway involves the activation of tin by twist, followed by the induction of dorsal mesodermal tin by dpp, then activation of bap by tin and dpp, activation of bin by bap and dpp, and finally activation of b Tub60D by the combined action of bap and bin. A second gene that is activated at the end of this cascade in the visceral mesoderm with a similar temporal, albeit more restricted spatial pattern as compared to bTub60D, is dpp. In the case of dpp, we have found that a visceral mesoderm-specific enhancer requires only Bin, but not Bap, as a direct activator (Zaffran et al., 2001) . Hence, genes controlling morphogenesis or differentiation of the visceral mesoderm differ in their requirement for either one or both of the ubiquitously distributed visceral mesoderm activators, Bap and Bin, as direct regulators. These differences may depend on the particular involvement of additional regulators, which in the case of dpp include spatially-restricted activities such as Ubx, that may obviate a requirement for Bap in addition to Bin as a direct activator.
Materials and methods

Drosophila strains and genetics
Drosophila strains were raised on standard cornmealyeast agar medium at 25 8C or at room temperature. The null allele bin
I1
, bap Df and bap3-lacZ #6 line were previously described in Zaffran et al. (2001) . The b3-14/ D Ubx1 1 2-lacZ line was described in Kremser et al. (1999) . All alleles were balanced over either TM3Sb p [ftz-lacZ] or TM3Sb p[eve-lacZ] to identify and examine homozygous embryos.
Construction of b 3 Tubulin vm1-lacZ transformation plasmids
The b3-17 element was obtained by PCR amplification on b3-15 DNA (Hinz et al., 1992) with appropriate oligonucleotides and then subcloned into pBluescript KS vector (Stratagene). All numbers of the b 3 tubulin midgut enhancer element cited in this study refer to the GenBank sequence X68393, with numbering relative to the start site of transcription. For the b3-17 fragment (13252/13506), primers b3-EcoRI GTAGAATTCGCCCCTCTCCGCTG-GGCCG and b 3-XhoI GAGCTCGAGGCGGCTGGCTT-GGCAACAGTCACCG were used.
For in vitro site-directed mutagenesis of vm1 enhancer elements, pBluescript KS b 3-17 was used as template in inverse PCR amplification. Appropriate oligonucleotides were designed to introduce a new restriction site replacing the Forkhead and NK-2 binding sites. For example to mutate the Bin I and Bin II in b 3-17 fragment the primer TGGGCCGTAAAAGCTTAAAGAAATGCAG and CTG-CATTTCTTTAAGCTTTTACGGCCCA introducing a HindIII site and CCAGTTCCCAGTGCCTTGTCGACTA-GTCGCACACG and CGTGTGCGACTAGTCGACAAG-GCACTGGGAACTGG introducing a SalI site were used. The primers GTCAGATATCAGTGCCAAAGGGAAAC and CACTGATATCTGACGTGTGCGACTAT were used to mutate the NK-2 binding site by introducing an EcoRV restriction site. All constructs were sequenced to confirm that only the intended mutations were introduced and were cloned into pCaSpeRhs43 bGal (Thummel and Pirrotta, 1992) . The resulting constructs were introduced into w 1118 embryos to generate transgenic flies by standard injection methods (Rubin and Spradling, 1982) and three independent lines showing identical expression patterns were examined for each construct.
Embryo staining
Whole-mount in situ hybridization and immunostaining were performed as described in Zaffran et al. (2001) . The following primary antibodies used in this study have been already described: Rabbit anti-b-galactosidase antibody (1:3000; Cappel) and rabbit anti-b3 tubulin antibody (1:1500; gift from R. Renkawitz-Pohl). For b3 tubulin and PS1 antibodies and dpp in situ fluorescent staining, Renaissance Tyramide Signal Amplification (NEN) was used in conjunction with the VectaStain ABC components. A Zeiss Axiophot and Leica TCS-SP confocal microscopes were used to analyze the stainings.
DNA-binding assay
DNaseI footprinting assays were performed as described in Zaffran et al. (2001) . Briefly, all b3-17 wild-type or mutated fragments were generated as single-end labeled probes. The DNA fragments were amplified with 5 0 phosphorylated and 3 0 unphosphorylated T3 or T7 primers and single-end-labeled with [g-32 P]ATP by T4 DNA polynucleotide kinase. A single-end-labeled b 3-17 fragment (0.25 mg/ml and 10 4 cpm) was incubated for 30 min on ice with different amounts of purified Biniou, Bagpipe or Tinman GST fusion proteins in the reaction mixture (50 mM KCl, 25 mM HEPES (pH 7.9), 6 mM MgCl 2 , 1 mM DTT, 10% glycerol, 1.5 mg poly(dI/dC)). The DNA/protein complex was treated with 5 £ 10 24 U of DNaseI (Roche Molecular Biochemicals) for 2 min on ice. The DNA fragments and sequencing lanes were loaded on 6% polyacrylamide/7.5 M urea gels. All GST fusion proteins were previously described in Zaffran et al. (2001) and Yin et al. (1997) .
Gel mobility shift assays with Biniou GST protein fusion were performed in a 10 ml volume on ice with 10 4 cpm (0.5 ng) of a 50 bp end-labeled DNA probe fragment and 0.5 mg of non-specific competitor poly(dI/dC) and 5-250 ng (10-500-fold molar excess) of specific competitor DNA in a final buffer composition of 4% Ficoll, 20 mM HEPES (pH 7.6), 50 mM KCl, 1 mM EDTA, 1 mM DTT and 0.25 mg BSA. Twenty nanograms of Biniou protein was gently added and incubated for 30 min, then loaded on a 4% polyacrylamide gel in 0:25£ TBE buffer. Gels were dried and exposed to Xray film for 12 h.
